A cross-sectional study of COPD and symptom variability in MEA countries

Trial Identifier:	D2287R00105
Sponsor:	AstraZeneca
NCTID::	NCT03425760
Start Date:	December 2015
Primary Completion Date:	March 2017
Study Completion Date:	March 2017
Condition:	Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.